This document discusses diagnosing and treating chronic musculoskeletal pain in working-aged adults. It begins by reviewing the evolution of pain models from the 1980s focusing on nociceptive and neuropathic pain to the modern understanding of a central sensitivity spectrum. Central sensitivity disorders like fibromyalgia, low back pain, and headache exist on a continuum and are characterized by widespread pain, comorbid somatic symptoms, and disproportionate central nervous system pain processing. Diagnosing these conditions involves assessing factors like family history of pain, high self-reported pain scores, tenderness on examination, and validated questionnaires. Treatments with the strongest evidence include patient education, graded exercise, cognitive behavioral therapy, and some medications, while opioids have weak evidence and high risks. The case
Fibromyalgia is a disease, which is difficult to diagnose. These slides include ACR criteria 1990 and 2010 with Wide spread pain index(WPI) and Symptom severity score(SSS)
Peripheral neuropathy is a common condition, encountered by physicians as well as neurologists. However, a large number of challenges remain. These include difficulty in diagnosing, delay in diagnosis, investigations and lack of effective treatments. This presentation discusses these unmet needs and provides suggestions to overcome them.
—Pain following Spinal Cord Injury (SCI) is very common. So this study was conducted to find out prevalence, associated factors and pattern of Neuropathic Pain (NP) among SCI patients, for which 494 consecutive eligible patients of Spinal Cord Injury (SCI) admitted in the Department were evaluated for NP. It was observed that 13.76% of SCI patients complained of neuropathic pain. In 21 to 30 years age group 23.13% and 61.76% cases of neuropathic pain had dorso-lumbar injury. 48.30% cases of neuropathic pain had onset in 2 nd and 3 rd week. Discomfort was more at night (36.76%), in below the knee area and dorsum of the foot. Hot burning type of sensation was the commonest descriptor of NP and range of movement (ROM) exercises and tepid cold water sponging were relieving factors.
Fibromyalgia can be resolved by medical herbalismmorwenna2
A recent public awareness survey by the National Fibromyalgia Association illustrates a significant lack of understanding about Fibromyalgia: nearly half of the general public (45%) has never heard of Fibromyalgia, many people who are knowledgeable about the disorder incorrectly believe that nothing can be done to manage it, and nearly half (48%) of all healthcare providers are reluctant to diagnose a patient with the condition (National Fibromyalgia Association, 2007).
Painful diabetic peripheral neuropathy: diagnosis and managementSudhir Kumar
Diabetes mellitus is a common illness and the prevalence has been increasing all over the world, especially in Asia and India. Diabetes leads to several complications, affecting kidneys, nerves, eyes, brain and heart. The involvement of nerves due to diabetes is called diabetic neuropathy, which can be painful and disabling. The current presentation looks at the symptoms and diagnosis of painful diabetic neuropathy and also the treatment options.
12.04.08(a): Pathogenesis and Treatment of FibromyalgiaOpen.Michigan
Slideshow is from the University of Michigan Medical School's M2 Musculoskeletal sequence
View additional course materials on Open.Michigan:
openmi.ch/med-M2Muscu
Fibromyalgia is a disease, which is difficult to diagnose. These slides include ACR criteria 1990 and 2010 with Wide spread pain index(WPI) and Symptom severity score(SSS)
Peripheral neuropathy is a common condition, encountered by physicians as well as neurologists. However, a large number of challenges remain. These include difficulty in diagnosing, delay in diagnosis, investigations and lack of effective treatments. This presentation discusses these unmet needs and provides suggestions to overcome them.
—Pain following Spinal Cord Injury (SCI) is very common. So this study was conducted to find out prevalence, associated factors and pattern of Neuropathic Pain (NP) among SCI patients, for which 494 consecutive eligible patients of Spinal Cord Injury (SCI) admitted in the Department were evaluated for NP. It was observed that 13.76% of SCI patients complained of neuropathic pain. In 21 to 30 years age group 23.13% and 61.76% cases of neuropathic pain had dorso-lumbar injury. 48.30% cases of neuropathic pain had onset in 2 nd and 3 rd week. Discomfort was more at night (36.76%), in below the knee area and dorsum of the foot. Hot burning type of sensation was the commonest descriptor of NP and range of movement (ROM) exercises and tepid cold water sponging were relieving factors.
Fibromyalgia can be resolved by medical herbalismmorwenna2
A recent public awareness survey by the National Fibromyalgia Association illustrates a significant lack of understanding about Fibromyalgia: nearly half of the general public (45%) has never heard of Fibromyalgia, many people who are knowledgeable about the disorder incorrectly believe that nothing can be done to manage it, and nearly half (48%) of all healthcare providers are reluctant to diagnose a patient with the condition (National Fibromyalgia Association, 2007).
Painful diabetic peripheral neuropathy: diagnosis and managementSudhir Kumar
Diabetes mellitus is a common illness and the prevalence has been increasing all over the world, especially in Asia and India. Diabetes leads to several complications, affecting kidneys, nerves, eyes, brain and heart. The involvement of nerves due to diabetes is called diabetic neuropathy, which can be painful and disabling. The current presentation looks at the symptoms and diagnosis of painful diabetic neuropathy and also the treatment options.
12.04.08(a): Pathogenesis and Treatment of FibromyalgiaOpen.Michigan
Slideshow is from the University of Michigan Medical School's M2 Musculoskeletal sequence
View additional course materials on Open.Michigan:
openmi.ch/med-M2Muscu
Brief Report: OSA Evaluations for the Anaesthesiologist, Surgeon, Surgery Centresemualkaira
This short report presents a scope of the medical condition of Obstructive Sleep Apnea (OSA). Current methods for assessment and
diagnosis of OSA are presented. Complications and potential death
from untreated OSA places the anesthesiologist, surgeon and surgical center in a risk situation. Factors related to the risk factors
and points toward resolution are presented.
ABSTRACT: IASP (International Association for study of pain) defined pain as “an unpleasant, sensory and
emotional experience associated with actual or potential tissue damage or described in terms of such damage”.
Chronic Pain can be more described as a disease rather than a symptom. Antidepressants are the drugs that can elevate
the mood. Recent trials have elucidated that anti- depressants can be of worth in treating chronic pain conditions.
However, the safe use of these drugs depends on upon the clinician or any other health professional and their ability to
choose the right tolerated drug at safe doses. Any psychiatric comorbidity must be treated to avail best results with
anti-depressant therapy.However, most of the trials focus upon only Tri-CyclicAntidepressants and Selective
Serotonin Reuptake Inhibitors. Research into other novel Anti-depressant drugs may lead to best chances of recovery
in patients with chronic pain.
Maladaptive movement and motor control impairments as underlying mechanismMeziat
Artigo (5) importante para a preparação para o curso de dor lombar crônica. "Diagnóstico e classificação da dor lombar crônica: Disfunções de movimento e de controle mal adaptativas como mecanismo principal." É antigo, algumas coisas mudaram, mas vale à pena ler.
Hendricks, la velle counseling modalities nfjca v3 n1 2014William Kritsonis
William Allan Kritsonis, Editor-in-Chief, NATIONAL FORUM JOURNALS (Founded 1982). Dr. LaVelle Henricks, Texas A&M University-Commerce and colleagues published in national refereed journal.
Dr. William Allan Kritsonis, Distinguished Alumnus, Central Washington University, College of Education and Professional Studies, Ellensburg, Washington; Invited Guest Lecturer, Oxford Round Table, University of Oxford, United Kingdom; Hall of Honor, Prairie View A&M University/Member of the Texas A&M University System.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
Explore our infographic on 'Essential Metrics for Palliative Care Management' which highlights key performance indicators crucial for enhancing the quality and efficiency of palliative care services.
This visual guide breaks down important metrics across four categories: Patient-Centered Metrics, Care Efficiency Metrics, Quality of Life Metrics, and Staff Metrics. Each section is designed to help healthcare professionals monitor and improve care delivery for patients facing serious illnesses. Understand how to implement these metrics in your palliative care practices for better outcomes and higher satisfaction levels.
the IUA Administrative Board and General Assembly meeting
MSK Pain Handout
1. Diagnosing & Treating
Working-Aged Adults With
Chronic Musculoskeletal
Pain
Paul C. Coelho, MD
Board Certified PM&R
Subspecialty Certified Pain Medicine
Disclosures
Paul Coelho,MD: No financial relationships to disclose.
2. Table of Contents
1. Early Pain Models
2. Modern Pain Models
3. FMS, LBP, HA as Central
Sensitivity Spectrum Disorders
4. Neuroanatomy of Central
Sensitivity Spectrum Disorders
5. Diagnosing Central
Sensitivity Spectrum Disorders
1980 Model of MSK Pain
Nociceptive Neuropathic
Primarily due to inflammation or
mechanical damage in periphery.
Damage or entrapment of peripheral
nerves.
NSAID, Opioid Responsive Responds to both peripheral and
central pharmacological therapy.
Responds to procedures. Does not respond to procedures.
Behavioral factors minor Behavioral factors minor
Examples: Osteoarthritis, Rheumatoid
Arthritis, Cancer Pain
Examples: Diabetic neuropathy, post-
herpetic neuralgia
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1829161/
3. 1990 FMS
https://www.rheumatology.org/Portals/0/Files/1990_Criteria_for_Classification_Fibro.pdf
Average Age = 45
1990 Model of MSK Pain
Nociceptive Neuropathic Central
Primarily due to
inflammation or
mechanical damage in
periphery.
Damage or entrapment of
peripheral nerves.
Primarily due to a central
disturbance in pain
processing.
NSAID, Opioid
Responsive
Responds to both
peripheral and central
pharmacological therapy.
Tricyclic neuro-active
Compounds. Opioid
unresponsive
Responds to procedures
Does not respond to
procedures
Does not respond to
procedures
Behavioral factors minor. Behavioral factors minor. Behavioral factors more
prominent.
Examples: Osteoarthritis,
Rheumatoid Arthritis,
Cancer Pain
Examples: Diabetic
neuropathy, Post-herpetic
neuralgia.
Examples: FMS, IBS,
Tension HA, idiopathic
LBP
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1829161/
4. Variation in Opioid Rx’ing
For FMS 2007-2009
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346177/
Mean Age = 44.7
High Dose CNP Patients
Often Those With FMS
http://www.ncbi.nlm.nih.gov/pubmed/24310048
Mean Age = 44.7
Mean Age = 49
5. Opioids & FMS: Once
Started Seldom Stopped
http://www.ncbi.nlm.nih.gov/pubmed/26443495
Average Age = 47
N = 96K Pt’s with FMS 59% Received Opioids
0
12500
25000
37500
50000
1980 1983 1986 1989 1992 1995 1998 2001 2004 2007 2010 2013
US Opioid Overdose Deaths 1980-2014
Wolfe/ACR FMS
1990
IOM 100M in Pain
2011
http://www.cdc.gov/nchs/data/databriefs/db81_tables.pdf#1
http://www.cdc.gov/nchs/data/health_policy/AADR_drug_poisoning_involving_OA_Heroin_US_2000-2014.pdf
Peak Incidence of Prescription ODD Age 45-54*
*http://www.cdc.gov/drugoverdose/data/overdose.html
FDA Approves OxyContin
1995
6. ‘Fibromyalgianess’&
Comorbid Pain Syndromes
Fibromyalgia exists on a continuum
“What the results of our study showed is that we provided reasonably
good evidence that fibromyalgia exists as a continuum rather than a
dichotomous diagnosis.”
Wolfe
Fibromyalgia co-occurs with many pain syndromes
“Data in recent years suggest that FMS is a part of a spectrum of
syndromes which I have termed “dysfunctional spectrum syndrome”.
Yunus
Prevalence of cLBP & HA
In FMS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1829161/
2007 Internet Survey of 2,596 people with fibromyalgia.
Average Age = 47
If due to chance alone
co-occurance of cLBP, cHA, &
FMS expected 0.1%
7. Prevalence of FMS
In cLBP Pt’s 42%
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345120/
Average Age 47
If due to chance alone .3 x .02 = .6%
Prevalence of FMS
In HA Pt’s 36%
http://www.ncbi.nlm.nih.gov/pubmed/19170692
Average Age 46
If due to chance alone .2 x .02 = .4%
8. HA & cLBP As Predictors of
FMS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715288/
Mean Age 28
Co-Morbid Pain in FMS is
the Norm
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1829161/
FMS
cHAcLBP
9. Co-Morbid Pain in FMS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1829161/
“Overwhelming evidence reveals that what is
often labeled as a single chronic regional pain
syndrome is, upon closer evaluation, a chronic
illness beginning much earlier in life, where the
pain merely occurs at different points of the body
at different points in time and is given different
labels by subspecialists focusing on “their region”
of the body.”
Daniel Clauw, MD
Central Sensitivity
Spectrum (CSS)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236313/pdf/PRT2012-584573.pdf
12. Pain Is A Perception
Not A Stimulus
http://onlinelibrary.wiley.com/doi/10.1111/j.1469-7580.2005.00428.x/epdf
No brain, no pain.
Somatotopic Pain Map In
The Spinal Cord
13. Where Is Somatotopic Map
For Pain In The Brain?
BOLD rs-fMRI
http://www.amazon.com/Brain-Adapting-Pain-Contribution-Neuroimaging/dp/1496317491/ref=tmm_pap_title_0?
_encoding=UTF8&qid=&sr=
Blood Oxygen Level Dependent
15. fMRI and Nociceptive Pain
2013
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691100/
Primary Somatosensory Cortex
Secondary Somatosensory Cortex
fMRI and Central Pain
2013
http://www.ncbi.nlm.nih.gov/pubmed/23983029
Pain chronification shifts brain representation from
nociceptive to emotional circuits.
Average Age 49Average Age 42
16. fMRI and Central Pain
2013
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691100/
Dorsal Anterior Cingulate
Limbic System
Nucleus Accumbens
The Reward Center
http://www.nejm.org/doi/full/10.1056/NEJMra1508490
Heroin is pharmacologically similar to
prescription opioids. All these drugs produce
their action through endogenous opioid systems
that regulate a wide range of functions through
three major types of G-protein–coupled
receptors: mu, delta, and kappa, with
particularly potent agonist activity at the mu
receptor and weak activity at the delta and
kappa receptors. Mu-receptor activation by an
agonist such as heroin or a prescription opioid
triggers a complex cascade of intracellular
signaling events, which ultimately lead to an
increase in dopamine release in the shell of the
nucleus accumbens. The resulting burst of
dopamine in this critical area of the reward
circuitry becomes strongly coupled with the
subjective “high” that is caused by drugs of
abuse.
17. Opioids Alter Brain
Function
http://www.ncbi.nlm.nih.gov/pubmed/20558415
Central Vs Nociceptive
Pain
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691100/
Central Pain
Opioid Unresponsive
Nociceptive Pain
Opioid Responsive
Pain: An unpleasant sensory and emotional experience associated with
actual or potential tissue damage, or described in terms of such damage.
19. CSS Diagnostic
Components
http://www.ncbi.nlm.nih.gov/pubmed/26266995
1. Pain in many body regions.
2. Higher current and lifetime history of chronic pain in several
body regions.
3. Multiple somatic symptoms (e.g., fatigue, memory difficulties,
sleep problems, mood disturbance)
4. More sensitive to other sensory stimuli (e.g., bright light, loud noises,
odors, other sensations in internal organs)
5. 1.5 to 2x more common in women.
6. Strong family history of chronic pain.
7. High self-reported pain & distress (VAS/NPS/PSD/PCS)
8. Pain triggered or exacerbated by stressors.
9. Peak prevalence of FMS age 50-59 (working-age).*
10. Essentially normal physical examination +/- diffuse tenderness.
* http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575027/
Current Wide-Spread Pain or
History of Wide-Spread Pain
20. Family History of Chronic
Pain
http://www.ncbi.nlm.nih.gov/pubmed/25096408
Family History of FMS
*http://www.ncbi.nlm.nih.gov/pubmed/15022338
22. Validated Instruments to
Detect Distress/CSS
“You cannot guess at the extent of fatigue,
unrefreshed sleep, cognitive problems,
multiplicity of symptoms, and extent of pain
without a detailed interview.”
Frederick Wolfe
http://www.ncbi.nlm.nih.gov/pubmed/20461781
Validated Instruments to
Detect Distress/CSS
1. Pain Catastrophizing Scale (PCS)
2. Fibromyalgia Survey Questionnaire (FMSQ/PSD)
3. Patient Health Questionnaire 15
2. McGill Pain Questionnaire (Sensory/Affective)
3. Modified Somatic Perceptions Questionnaire
4. Central Sensitivity Index
Measures of “Fibromyalgianess”
25. Natural Hx of FMS
https://www.researchgate.net/profile/Winfried_Haeuser/publication/
51498368_The_longitudinal_outcome_of_fibromyalgia_a_study_of_1555_patients/links/0fcfd505a26be3b078000000.pdf
Average Age = 53
FMS & SSD
http://onlinelibrary.wiley.com/doi/10.1002/acr.22305/epdf
Average Age 53.4
26. Disabled Medicare < 65yrs
Receiving Opioids
http://journals.lww.com/lww-medicalcare/Fulltext/2014/09000/Prescription_Opioid_Use_Among_Disabled_Medicare.13.aspx
Future Treatments
http://www.ncbi.nlm.nih.gov/pubmed/26088211
Currently available treatments for CSSs are empirical, palliative, and
provide only modest benefits.
28. Sample Case
Mrs. C: 50y/o WF with chronic
Lt thumb pain due to xyz. Referred for
medication recommendations.
PMH/Pain Hx
Patient denied any.
FHX of chronic pain: + Mother & Sibling
Meds: Oxycodone 5mg po TID* & Hydro-
codone -APAP 5/325 QID = MED 55
Sample Case
9
9
x
x x
x
x
x
x
OO
30. Sample Case
xx
x
x
x
x
x
x
x
4
4
4
4
4
4
4
4
4
4
4
4
4
52/52
Nl < 30
Sample Case
Chart Review:
Long history of chronic multifocal
pain dating back many years and
including visits to multiple pain
providers.
PMH: Neck pain, HA, Back and Leg
pain.
Epic OHSU:
15 visits to OHSU’s pain program in
2013
Dx with chronic neck pain, HA,
Depression
FMS.
31. Sample Case
Ddx:
1. Hand pain M79.6
2. Somatic Symptom Disorder
F45.42
3. Chronic Pain
G89.4
What are your recommendations
for Mrs. C?
Brain Pain
http://www.amazon.com/Brain-Adapting-Pain-Contribution-Neuroimaging/dp/1496317491/ref=tmm_pap_title_0?
_encoding=UTF8&qid=&sr=